NEW YORK (GenomeWeb) – Strata Oncology announced today that it has closed a $26 million Series B funding round.
Existing investors Arboretum Ventures and Baird Capital were joined in the round by new investors Pfizer Ventures, Merck Global Health Innovation Fund, Deerfield Management, and Renaissance Venture Capital Fund.